Keynote Speakers

  • Dr Sang-Jae Park

    Director, Research Institute of National Cancer Center, Korea & Staff Surgeon, Cancer for Liver Cancer/ Liver and Pancreatobiliary Pancreatic Cancer Branch, National Cancer Center, Korea

    Is it Possible to Cure Pancreas Cancer in the Era of Precision Medicine?

  • Catherine SC Teh, MD, FPCS, FRCSEd

    President, Philippine Association of HPB Surgeons

    Approach to Management of Colorectal Liver Metastasis in 2020

  • Dr Shin-E Wang

    Division of General Surgery, Department of Surgery, Taipei Veterans General Hospital, Taiwan

    How does Robotic Pancreatic Surgery compare with Laparoscopic Surgery?

  • Professor Rowan W. Parks

    Vice President of the Royal College of Surgeons of Edinburgh (RCSEd); Deputy Director of Medicine, NHS Education for Scotland (NES) and Treasurer of the European-African Hepato-Pancreatico-Biliary Association (E-AHPBA)

    Current Management of Biliary Complications Following Major HPB Surgery

  • Professor Pierre-Alain Clavien

    Professor and Chair, Department of Surgery, Division of Surgery & Transplantation, University Hospital Zurich

    What are the Essential Requirements for an HPB Service to Deliver Quality Outcomes?

  • Professor Laurence Chiche

    Professor of Surgery and Director for the Department of Surgery at Bordeaux University Hospital, France

    Managing Patients with Liver Adenomas

  • Professor Barbara Wildhaber

    Professor, Chief of Pediatric Surgery, Geneva University Hospitals

    Managing Children with Hepatoblastoma

  • Associate Professor Tara Kent

    Associate Professor of Surgery, Harvard Medical School

    Patient-Centered Decision-Making for Pancreas Cancer

  • Dr Timothy Pawlik

    Professor and Chair, Department of Surgery The Urban Meyer III and Shelley Meyer Chair for Cancer Research Wexner Medical Center at The Ohio State University

    Contemporary Management of Intrahepatic Cholangiocarcinoma

  • Dr Horacio Asbun

    Chief of Hepatobiliary and Pancreatic Surgery at Miami Cancer Institute and Professor of Surgery at Mayo Clinic College of Medicine and Science

    Laparoscopic Surgery for Pancreatic Head Malignancies: Evidence Based Perspective

  • Dr Satoru Todo

    Japan

    Thomas Starzl Memorial Lecture
    Immune Tolerance in Liver Transplantation; Current and Future

Dr Sang-Jae Park

Director, Research Institute of National Cancer Center, Korea & Staff Surgeon, Cancer for Liver Cancer/ Liver and Pancreatobiliary Pancreatic Cancer Branch, National Cancer Center, Korea

Is it Possible to Cure Pancreas Cancer in the Era of Precision Medicine?

Dr Sang-Jae Park is the Director, Research Institute of National Cancer Center, Korea & Staff Surgeon, Cancer for Liver Cancer/ Liver and Pancreatobiliary Pancreatic Cancer Branch, National Cancer Center, Korea

Education

  1. 1984-1990 | M.D. Seoul National University College of Medicine, Seoul, Korea
  2. 1994-1999 | M.S. Seoul National University College of Medicine, Seoul, Korea
  3. 2000-2004 | ph.D. Seoul National University College of Medicine, Seoul, Korea

Training

  1. 1991-1995 | Residency in General Surgery, Seoul National University Hospital, Seoul, Korea
  2. 1998-2000 | Fellowship in General Surgery, Seoul National University Hospital, Seoul, Korea
  3. 2006-2007 | Research fellow at the Transplantation Division in UCSF, USA

Faculty Appointment

  1. 2000-present | Center for Liver Cancer, National Cancer Center, Korea | Liver and Pancreatobiliary Cancer Branch, National Cancer Center, Korea
  2. 2010-2014 | Head, Center for Liver Cancer, National Cancer Center, Korea
  3. 2014-2017 | Head, Dep. of Surgery, National Cancer Center Hospital, Korea
  4. 2018-present | Director, Research Institute of National Cancer Center, Korea

Academic Activities

  • 2017-present | Director, Scientific Committee of Korean Association of HBP Surgery
  • 2008-2009 | Secretary, Korean Liver Cancer Association
  • 1995-present | Member, Korean Surgical Society
  • 2001-present | Member, Korean Association of HBP Surgery
  • 2002-present | Member, Korean Liver Cancer Association
  • 2005-present | Member, International Society of HBP Surgery
  • 2006-present | Member, International Society of Pancreatology

Publications

  • International 94, Korean 13

Catherine SC Teh, MD, FPCS, FRCSEd

President, Philippine Association of HPB Surgeons

Approach to Management of Colorectal Liver Metastasis in 2020

President, Philippine Association of HPB Surgeons

Director, PCS Cancer Commission Surgical Quality Improvement Program

 

President, ASEAN Lap HPB Alliance

 

Chief of Section of HPB Surgery
Makati Medical Center

Co-Director

NKTI Liver Center

 

Active Senior Consultant

Sections of HPB Surgery, Minimally Invasive Surgery & Surgical Oncology

Department of Surgery

St Lukes Medical Center

 

 

President and Founder
Samahang Minamahal ang Atay
Patients at the of all we do

http://liversurgeon.ph

Dr Shin-E Wang

Division of General Surgery, Department of Surgery, Taipei Veterans General Hospital, Taiwan

How does Robotic Pancreatic Surgery compare with Laparoscopic Surgery?

Dr. Shin-E Wang was graduated from National Yang Ming University in 2002, and completed her surgical residency at Taipei Veterans General Hospital from 2002 to 2007. She is currently working as an associate professor, Chief of minimally Invasive Surgery and attending surgeon in the division of General Surgery, Taipei Veterans General Hospital and National Yang Ming University. Her major interests include minimal invasive surgery including robotic and laparoscopic surgery, pancreas surgery and pancreas transplant. Her team is very actively involved in minimal invasive surgery, especially robotic Whipple operation (more than 345 RPD cases) and pancreas transplant (more than 165 cases). She was the experts committee member in International Evidence-Based Guidelines for Minimally Invasive Pancreatic Resection 2019 (IG-MIPR 2019), held at Miami.

Professor Rowan W. Parks

Vice President of the Royal College of Surgeons of Edinburgh (RCSEd); Deputy Director of Medicine, NHS Education for Scotland (NES) and Treasurer of the European-African Hepato-Pancreatico-Biliary Association (E-AHPBA)

Current Management of Biliary Complications Following Major HPB Surgery

Professor Rowan W. Parks qualified from Queens University Belfast in 1989. He pursued his surgical training in Northern Ireland and then undertook a clinical fellowship in HPB surgery at the Royal Infirmary of Edinburgh. He was appointed a Senior Lecturer in Surgery and Honorary Consultant Surgeon in the Royal Infirmary of Edinburgh in 1999, was subsequently promoted to Reader in Surgery in 2006 and was awarded a person chair as Professor of Surgical Sciences at the University of Edinburgh in 2010.

Professor Parks has a specialist interest in HPB surgery. He has published more than 160 papers, written 39 book chapters and has authored / edited 7 surgical textbooks. He has been awarded several prestigious prizes and travelling fellowships and has given a number of eponymous lectures.

Professor Parks is currently Vice President of the Royal College of Surgeons of Edinburgh (RCSEd); Deputy Director of Medicine, NHS Education for Scotland (NES) and Treasurer of the European-African Hepato-Pancreatico-Biliary Association (E-AHPBA). He is also immediate Past-President of the Association of Surgeons of Great Britain and Ireland (ASGBI); Immediate Past-President of the Great Britain & Ireland Hepato-Pancreato-Biliary Association (GBIHPBA);

Immediate Past-Chairman of the Scientific Programme Committee of the International Hepato-Pancreato–Biliary Association (IHPBA) and Past-Director of the James IV Association.

Professor Pierre-Alain Clavien

Professor and Chair, Department of Surgery, Division of Surgery & Transplantation, University Hospital Zurich

What are the Essential Requirements for an HPB Service to Deliver Quality Outcomes?

Pierre-Alain Clavien, MD, PhD, FACS (hon), ASA (hon), FRCS (Eng), FRCS (Ed), is a worldwide renowned surgeon-scientist, currently professor and chairman of the Department of Surgery in Zurich, Division of Surgery & Transplantation, University Hospital Zurich, Switzerland. His main interests are the various aspects of transplantation and liver surgery. Since 1994, he has been running an active basic science laboratory, areas of research include organ preservation, liver ischemia-reperfusion injury and liver regeneration, pathogenesis of cancer as well as outcome research with publication in Science, Nature, PNAS, Annals of Surgery, Gastroenterology, Lancet and NEJM. Dr. Clavien has also developed a simple and widely used system to evaluate complications after surgery, which holds his name.

He was appointed Associate Editor of Journal of Hepatology and of Annals of Surgery to cover the liver topics, and Editor for the ESA articles in Annals of Surgery.

Professor Laurence Chiche

Professor of Surgery and Director for the Department of Surgery at Bordeaux University Hospital, France

Managing Patients with Liver Adenomas

Present position :

Chief of the department of Digestive Surgery, University Hospital – Bordeaux, France (75 beds) 7 operating rooms

Head of the program of Liver transplantation of Bordeaux (70 per y)

University Course

1990-1993 Senior resident: Liver surgery and transplantation department  Paul Brousse; Pr Bismuth, Villejuif, France

1994- 2003: Assistant surgeon University Hospital of Caen, France

2003- 2012: Professor  of digestive surgery, Caen

2012 until now: Professor of Digestive and transplantation  Surgery, Bordeaux

Consensus conference participant or leader

indications of Liver transplantation  (1993- 2003)

Good practice of liver biopsy (2001)

Recommendations for Clinical Practice in Colorectal Liver metastasis (2003)

Carcinologic rules in digestive surgery (2009)

Non-colorectal liver metastasis (2010)

National responsibilities

Ex-Secretary of the French Association of Liver Surgery and Transplantation

Ex-member of the National University Committee of Digestive Surgery

Expert at the French Liver Transplantation Regulation Agency

Member of the National Committee of surgical qualification

Member of Associations

French associations: ACHBT, AFC (President of the 2020 congress)

International: European Surgical Association (ESA)

Honoris member of the Portuguese Surgical  Association

Honoris Fellow of the American College of Surgeons (2019) (FACS, Hon)

Member of the American Society Association (2020)

Hepato biliary Companion (International Society created by H. Bismuth)

Clinical activities

Liver surgery (250 hepatectomies per year )

Pancreatic surgery (100/y)

Liver transplantation (80/y)

Research program

President of the group of research ARCHET (liver surgery and Transplantation group Rennes, Lyon, Toulouse, Bordeaux)

President of GRAPA ( group of clinical and experimental research on Pancreatic carcinoma

Field of research (Inserm): adenomas, HCC, pancreatic cancer

Director of PhD (E Buscail) and Jury member of PhD programs

Teaching responsibilities

Responsible of the teaching program for french digestive surgical residents

Chevalier de la légion d’Honneur

Professor Barbara Wildhaber

Professor, Chief of Pediatric Surgery, Geneva University Hospitals

Managing Children with Hepatoblastoma

Barbara Wildhaber was born in Switzerland in 1969. She graduated from the University of Zurich in 1994 and then trained in paediatric surgery in Switzerland, the United States and South Africa and obtained her diploma as a specialized paediatric surgeon in 2005. She then further specialized in paediatric hepatobiliary surgery and liver transplantation in Paris and Geneva. In 2010, she was appointed professor at the faculty of medicine at the University of Geneva, head of the division of paediatric surgery and surgical director of the Swiss Paediatric Liver Centre at the Geneva University Hospitals. In 2014, she was further designated director of the University Centre of Paediatric Surgery of Western Switzerland, which pools expertise in paediatric surgery from the French part of the country. In the same year, she was appointed professor at the faculty of biology and medicine at the University of Lausanne. Within academia, Barbara Wildhaber has led numerous research projects in her areas of expertise. She sits on the executive boards of various scientific journals, foundations and scholarly associations, including the Swiss Academy of Medical Science and the International Committee of the Red Cross.

Associate Professor Tara Kent

Associate Professor of Surgery, Harvard Medical School

Tara S. Kent, MD, MS is an Associate Professor in Surgery at Harvard Medical School and a general and HPB surgeon at Beth Israel Deaconess Medical Center. Her clinical interests include benign and malignant pancreatic, biliary, and ampullary disease. Dr. Kent graduated from the Weill Cornell Medical College and then trained in general surgery at Albert Einstein College of Medicine/Montefiore Medical Center in New York. During residency, she completed a research fellowship in surgical oncology and obtained a Master’s of Science in Clinical Research Methodology from Einstein. While at BIDMC, she has completed the Rabkin Fellowship in Medical Education and is currently a Morgan-Zinsser fellow of the HMS Academy.

Dr. Kent is the program director of the general surgery residency at Beth Israel Deaconess Medical Center and the Vice Chair for Education in the BIDMC Department of Surgery. She is an Associate Editor of HPB and on the editorial boards of the Journal of Surgical Education and the Journal of Gastrointestinal Surgery. She has been involved in the Americas Hepato-Pancreato-Biliary Association since 2008, where she is a member of the Executive Council and the Vice Program Chair, having recently completed her term as Chair of the Education & Training Committee. She is also a member of the Education & Training Committee of the IHPBA. Dr. Kent is an Associate Member of the American College of Surgeons Academy of Master Surgeon Educators. In addition, she is a member of the Research Committee of the Association of Program Directors in Surgery.

Dr. Kent’s research focuses on surgical education, in particular on the learning environment in surgical residency and curricular innovations, and on patient-centered outcomes in pancreatic surgery. She is currently a co-investigator on a multicenter R01 grant evaluating a cultural dexterity curriculum for surgical residents, and she serves as a technical advisor for a USAID grant, ImpactMED, that involves surgical education in Vietnam.

Dr Timothy Pawlik

Professor and Chair, Department of Surgery The Urban Meyer III and Shelley Meyer Chair for Cancer Research Wexner Medical Center at The Ohio State University

Contemporary Management of Intrahepatic Cholangiocarcinoma

Dr. Pawlik received his undergraduate degree from Georgetown University and his medical degree from Tufts University School of Medicine. Dr. Pawlik completed surgical training at the University of Michigan Hospital and spent two years at the Massachusetts General Hospital as a surgical oncology research fellow. He then went on for advanced training in surgical oncology at The University of Texas M. D. Anderson Cancer Center in Houston. Dr. Pawlik’s main clinical interests include alimentary tract surgery, with a special interest in hepatic, pancreatic and biliary diseases. Dr. Pawlik also has an interest in medical ethics and completed a fellowship in medical ethics at the Harvard School of Public Health as well as a Masters in Theology from Harvard Divinity School in Boston. In addition, Dr. Pawlik was the recipient of a Clinical and Translational Science Award (CTSA) KL2 Research Scholar Award and received a PhD from the Johns Hopkins Bloomberg School of Public Health in Clinical Investigations.

Dr. Pawlik took his first faculty appointment at Johns Hopkins in 2005, where he was Professor of Surgery and Oncology, as well as the John L. Cameron Chair of Alimentary Tract Diseases and the Chief of the Division of Surgical Oncology until 2016. Dr. Pawlik currently is the Chair of Surgery at The Ohio State University Wexner Medical Center where he holds The Urban Meyer III and Shelley Meyer Chair for Cancer Research. Dr. Pawlik also serves as the Treasurer / Secretary of The Ohio State University Practice Plan. Dr. Pawlik has given over 450 invited talks both nationally and internationally in 30 different countries. Dr. Pawlik has published over 1,000 articles and 90 book chapters, in addition to editing eight surgical textbooks. His research has been cited over 35,000 times with an H-index of 98. Dr. Pawlik serves on multiple editorial boards and is Editor-in-Chief of Journal of Gastrointestinal Surgery, Deputy Editor of JAMA Surgery, as well as an Associate Editor for Annals of Surgical Oncology. Dr. Pawlik has served on the executive council of several of the premier surgical associations in the United States. Dr. Pawlik is a member of multiple surgical societies including the Society of Surgical Oncology, Society of Surgery of the Alimentary Tract, American Surgical Association, Halsted Society, and Society of Clinical Surgery. Dr. Pawlik is a past-President of the Association for Academic Surgery, as well as the current President-elect of the Americas Hepato-Pancreato-Biliary Association. Dr. Pawlik’s international contributions have been recognized through his honorary memberships in the Royal Australasian College of Surgeons, Brazilian Society of Surgical Oncology, Mexican Association for Surgery of the Alimentary Tract, as well as the Society of General Surgeons of Perú. Dr. Pawlik’s research focuses on determinations of factors associated with prognosis and staging of gastrointestinal cancers, as well as the economics of cancer care. He also studies patient/physician communication and patient engagement, as well as patient perception of cancer-care goals. Dr. Pawlik has consistently been recognized by Castle Connolly as one of America’s “Top Docs.”

Dr Horacio Asbun

Chief of Hepatobiliary and Pancreatic Surgery at Miami Cancer Institute and Professor of Surgery at Mayo Clinic College of Medicine and Science

Laparoscopic Surgery for Pancreatic Head Malignancies: Evidence Based Perspective

Horacio Asbun, M.D., FACS, is  Chief of Hepatobiliary and Pancreatic Surgery at Miami Cancer Institute and Professor of Surgery at Mayo Clinic College of Medicine and Science. Prior to this role, he served as Chairman of General Surgery at Mayo Clinic in Jacksonville, Fla.. (2008-2018)

Dr. Asbun is President-Elect and will be President (2020-2021) of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) and Executive Member of the Board of Governors. He also has served as a member of the Executive Council of the American Hepato-Pancreatic Biliary Association (AHPBA), Chairman of the Video-Based Education of the American College of Surgeons and is a founding Board Member of The G4 Alliance, the International Laparoscopic Liver Society and the International Minimally Invasive Pancreas Surgery consortium

Dr Asbun is the Editor-in-Chief of the American College of Surgeons Multimedia Atlas of Surgery and is on the Editorial Board of Surgical Endoscopy. He has served as a panel member on the National Comprehensive Cancer Network (NCCN) guidelines for pancreatic cancer and a member of 25 Medical Societies He has been, and currently is a member, Chair or Co-Chair of multiple Committees on several major US surgical societies

Dr Asbun is a member of multiple international expert’s surgical initiatives and expert study groups. Among them, International Study Group of Pancreas Surgery (ISGPS), Tokyo Guidelines (TG 18), European Guidelines on Laparoscopic Liver Surgery (EGMLLS), International Consensus on Laparoscopic Liver Resection (ICLLR), International Consensus on Prevention of Bile Duct Injury. He has served as the Chair of the Evidence-Based, International Guidelines in Minimally Invasive Pancreas Resection (IG-MIPR). He is also a founding member of the International Minimally Invasive Pancreas Surgery Consortium (IMIPS).

Dr Asbun has published more than 150 peered-reviewed scientific articles and 110 peer-reviewed surgical videos. He is author of over 35 book chapters and editor of 6 Surgical Books. He serves as a reviewer for numerous scientific journals. He directs and teaches national and international courses on surgery and speaks frequently at scientific conferences around the world, with, to-date, more than 240 presentations in the US and over 450 invited presentations in Europe, Asia, Africa, Oceania, Central and South America. He is an Honorary Fellow of several International Surgical Societies and has received multiple awards.

His publications are in the areas of liver, pancreas, biliary and endocrine surgery, minimal invasive surgery, surgical oncology, as well as basic science research in the field of surgical oncology.

Dr Satoru Todo

Japan

Immune Tolerance in Liver Transplantation; Current and Future

Dr Satoru Todo is devoted to evolving liver and intestinal transplantations. His major research includes immune suppression and organ preservation.